DDIS-09. IDENTIFICATION OF GSK3β INHIBITOR KENPAULLONE AS A TEMOZOLOMIDE ENHANCER AGAINST GLIOBLASTOMA

Cancer stem cells are associated with chemoresistance and rapid recurrence of malignant tumors including glioblastoma (GBM). Although temozolomide (TMZ) is the most effective drug against GBM to date, GBM cells acquire resistance and become refractory to TMZ during treatment. Therefore, glioma stem...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Kitabayashi, Tomohiro, Dong, Yu, Furuta, Takuya, Sabit, Hemragul, Jiapaer, Shabierjiang, Zhang, Jiakang, Zhang, Guangtao, Nakada, Mitsutoshi
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2018
Предметы:
Abstracts
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216549/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.288
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы